Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males

Review (20 RCTs; n=31,940) found the immunogenicity of 2-dose and 3-dose HPV vaccine schedules, measured using antibody responses in young females, is comparable, whilst the quadrivalent vaccine probably reduces external genital lesions and anogenital warts in males vs. control.


Cochrane Database of Systematic Reviews